Pure Global

BD CD45RA (L48) PE-Cy7 - HSA Registration DE0509840

Access comprehensive regulatory information for BD CD45RA (L48) PE-Cy7 in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0509840 and owned by Becton, Dickinson & Company. The device was registered on September 25, 2024.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS C IVD
DE0509840
BD CD45RA (L48) PE-Cy7
HSA Registration Number: DE0509840
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

CD45RA(L48) is intended for invitro diagnostic use in the identification of cells expressing the CD45RA antigen in peripheral blood, using a BD FACSLyric™ flow cytometer. Expression of the CD45RA antigen in the characterization of subjects having, or suspected of having hematological neoplasia.

Device Classification
Device Class
CLASS C IVD
Medical Speciality Area
Clinical chemistry
Registration Information
Registration Number
DE0509840
Registration Date
September 25, 2024
Retention Due Date
September 24, 2025
Product Owner
Short Name
Becton, Dickinson & Company
Address
Becton, Dickinson and Company, BD Biosciences, 155 North McCarthy Boulevard, Milpitas, California 95035, UNITED STATES
Registrant
Address
10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Importer
Address
10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Model Information
Model Name(s)
BD CD45RA (L48) PE-Cy7
Model Identifier(s)
337186